BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 25343843)

  • 21. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
    Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
    Zhang J; Li Y; Tao GZ; Chen YD; Hu TH; Cao XB; Jing QM; Wang XZ; Ma YY; Wang G; Liu HW; Wang B; Xu K; Li J; Deng J; Han YL
    Chin Med J (Engl); 2015 Mar; 128(6):784-9. PubMed ID: 25758273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.
    Giacoppo D; Capodanno D; Capranzano P; Aruta P; Tamburino C
    Am J Cardiol; 2014 Aug; 114(4):541-8. PubMed ID: 25001154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials.
    Thompson K; Razi R; Lee MS; Shen A; Stone GW; Hiremath S; Mehran R; Brar SS
    EuroIntervention; 2016 Jun; 12(3):366-74. PubMed ID: 25982920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Statins in Preventing Contrast-Induced Acute Kidney Injury: A Narrative Review.
    Akyuz S; Yaylak B; Altay S; Kasikcioglu H; Cam N
    Angiology; 2015 Sep; 66(8):701-7. PubMed ID: 25192700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
    Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
    García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
    Murat SN; Kurtul A; Yarlioglues M
    Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.
    Giacoppo D; Madhavan MV; Baber U; Warren J; Bansilal S; Witzenbichler B; Dangas GD; Kirtane AJ; Xu K; Kornowski R; Brener SJ; Généreux P; Stone GW; Mehran R
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002475. PubMed ID: 26198286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
    Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
    Toso A; Leoncini M; Maioli M; Tropeano F; Villani S; Bellandi F
    Cardiorenal Med; 2020; 10(5):288-301. PubMed ID: 32434204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis.
    Cho A; Lee YK; Sohn SY
    Medicine (Baltimore); 2020 Mar; 99(10):e19473. PubMed ID: 32150109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.